Literature DB >> 18941958

Estimating the prevalence of schizophrenia among New Zealand Maori: a capture-recapture approach.

Tai R Kake1, Richard Arnold, Pete Ellis.   

Abstract

OBJECTIVE: The aim of the present study was to estimate the 12 month prevalence of schizophrenia in the Maori population of New Zealand.
METHOD: Mental health data from two national sources were obtained for the period 2000-2003. A simple count of unique individuals with schizophrenia was used to estimate contact prevalence and a four-list capture-recapture procedure to estimate population prevalence.
RESULTS: Contact prevalence was significantly lower than the estimated population prevalence for both groups. The estimated 12 month prevalence of schizophrenia for Maori (0.97%) was significantly higher than for non-Maori (0.32%), even after adjustment for age, case under-ascertainment, and socioeconomic deprivation.
CONCLUSIONS: The prevalence of schizophrenia among Maori appears to be elevated, although limitations in diagnostic reliability and recording of ethnicity must be considered. This adds further evidence of worldwide variation in the prevalence of schizophrenia. Capture-recapture provides a reliable cost-effective alternative to epidemiological surveys for estimating the prevalence of low-prevalence disorders such as schizophrenia.

Entities:  

Mesh:

Year:  2008        PMID: 18941958     DOI: 10.1080/00048670802415376

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  8 in total

1.  Lessons Learned in Clinical Research Recruitment of Immigrants and Minority Group Members with First-Episode Psychosis.

Authors:  Mercedes Hernandez; Richard Franco; Alex Kopelowicz; Maria Y Hernandez; Yesenia Mejia; Concepción Barrio; Steven Regeser López
Journal:  J Immigr Minor Health       Date:  2019-02

2.  Steady-State Clozapine and Norclozapine Pharmacokinetics in Maori and European Patients.

Authors:  David B Menkes; Paul Glue; Christopher Gale; Frederic Lam; Cheung-Tak Hung; Noelyn Hung
Journal:  EBioMedicine       Date:  2017-12-13       Impact factor: 8.143

3.  Testing a hypothesis arising from the epidemiology of schizophrenia in New Zealand.

Authors:  Graham Mellsop; Rees Tapsell; David Benjamin Menkes
Journal:  Gen Psychiatr       Date:  2019-04-14

4.  Calculating incidence rates and prevalence proportions: not as simple as it seems.

Authors:  Inge Spronk; Joke C Korevaar; René Poos; Rodrigo Davids; Henk Hilderink; François G Schellevis; Robert A Verheij; Mark M J Nielen
Journal:  BMC Public Health       Date:  2019-05-06       Impact factor: 3.295

5.  Mental health service users' progression from illicit drug use to schizophrenia in New Zealand.

Authors:  Graham Mellsop; Rees Tapsell; Pragya Holmes
Journal:  Gen Psychiatr       Date:  2019-09-05

Review 6.  An evaluation of variation in published estimates of schizophrenia prevalence from 1990─2013: a systematic literature review.

Authors:  Jason C Simeone; Alexandra J Ward; Philip Rotella; Jenna Collins; Ricarda Windisch
Journal:  BMC Psychiatry       Date:  2015-08-12       Impact factor: 3.630

Review 7.  Prevalence of psychotic disorders and its association with methodological issues. A systematic review and meta-analyses.

Authors:  Berta Moreno-Küstner; Carlos Martín; Loly Pastor
Journal:  PLoS One       Date:  2018-04-12       Impact factor: 3.240

Review 8.  The definition and measurement of heterogeneity.

Authors:  Abraham Nunes; Thomas Trappenberg; Martin Alda
Journal:  Transl Psychiatry       Date:  2020-08-24       Impact factor: 6.222

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.